Hedge Fund Filings: After-Market 13D Watch

2) James Roumell and Roumell Asset Management, whom we track, owns shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT). The purpose of today's filing was to disclose this letter, in which Roumell...... (read more)